The problem of fighting antibiotic resistances, optimizing antibiotic usage and patients' care is one of the topics on which the scientific community is currently operating. For this purpose, the European Union has financed in 2012 a cross border project, involving Italy and France, focused on the design of a platform for the collection of data...
-
2014 (v1)PublicationUploaded on: December 5, 2022
-
2013 (v1)Publication
Introduzione. Nonostante gli indiscutibili successi ottenuti con la HAART, alcuni pazienti con infezione da HIV necessitano di ricovero ospedaliero per l'insorgere di comorbidita'. Obiettivo del nostro lavoro รจ definire le cause che rendono necessaria l'ospedalizzazione nei pazienti con infezione da HIV nella nostra regione. Pazienti e...
Uploaded on: April 14, 2023 -
2011 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2017 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2014 (v1)Publication
INTRODUCTION: The persistence of immune activation and inflammation in HIV patients with HIV-RNA (VL) undetectable causes many co-morbidities [1-3]. The aim of this study is to correlate monocytes (m) and NK cell activation levels, soluble markers and oxidative stress with clinical, biochemical and metabolic data in HIV-1 infected patients...
Uploaded on: April 14, 2023 -
2012 (v1)Publication
Purpose of the study: Promising research suggest that maraviroc (MVC) has favourable clinical outcome in HIV-infected patients (pts). Aim of the study is to assess: durability, safety profile and immunovirological recovery in a large MVC-based cohort. Methods: All HIV pts treated with antiretroviral therapy (ART) containing MVC for at least 6...
Uploaded on: April 14, 2023